ID   HIPK3_RAT               Reviewed;        1191 AA.
AC   O88850;
DT   15-MAR-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   24-JUL-2024, entry version 123.
DE   RecName: Full=Homeodomain-interacting protein kinase 3;
DE            EC=2.7.11.1;
DE   AltName: Full=Androgen receptor-interacting nuclear protein kinase;
DE            Short=ANPK;
GN   Name=Hipk3; Synonyms=Fist;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], SUBCELLULAR LOCATION, MUTAGENESIS OF LYS-226;
RP   SER-357 AND TYR-359, AUTOPHOSPHORYLATION, INTERACTION WITH AR, AND
RP   FUNCTION.
RC   TISSUE=Testis;
RX   PubMed=9725910; DOI=10.1091/mbc.9.9.2527;
RA   Moilanen A.-M., Karvonen U., Poukka H., Jaenne O.A., Palvimo J.J.;
RT   "Activation of androgen receptor function by a novel nuclear protein
RT   kinase.";
RL   Mol. Biol. Cell 9:2527-2543(1998).
CC   -!- FUNCTION: Seems to negatively regulate apoptosis by promoting FADD
CC       phosphorylation. Enhances androgen receptor-mediated transcription. May
CC       act as a transcriptional corepressor for NK homeodomain transcription
CC       factors. {ECO:0000269|PubMed:9725910}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1;
CC   -!- SUBUNIT: Interacts with Nkx1-2. Interacts with FAS and DAXX. Probably
CC       part of a complex consisting of HIPK3, FAS and FADD. Interacts with
CC       UBL1/SUMO-1 (By similarity). Interacts with and stabilizes ligand-bound
CC       androgen receptor (AR). {ECO:0000250, ECO:0000269|PubMed:9725910}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:9725910}.
CC   -!- PTM: Autophosphorylated. Autophosphorylation is not required for
CC       catalytic activity.
CC   -!- PTM: May be sumoylated. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CMGC Ser/Thr
CC       protein kinase family. HIPK subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF036959; AAC35249.1; -; mRNA.
DR   PIR; T14154; T14154.
DR   RefSeq; NP_113975.1; NM_031787.1.
DR   AlphaFoldDB; O88850; -.
DR   SMR; O88850; -.
DR   DIP; DIP-5932N; -.
DR   STRING; 10116.ENSRNOP00000073200; -.
DR   iPTMnet; O88850; -.
DR   PhosphoSitePlus; O88850; -.
DR   PaxDb; 10116-ENSRNOP00000015775; -.
DR   GeneID; 83617; -.
DR   KEGG; rno:83617; -.
DR   UCSC; RGD:619884; rat.
DR   AGR; RGD:619884; -.
DR   CTD; 10114; -.
DR   RGD; 619884; Hipk3.
DR   eggNOG; KOG0667; Eukaryota.
DR   InParanoid; O88850; -.
DR   OrthoDB; 3095114at2759; -.
DR   PRO; PR:O88850; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0016605; C:PML body; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; ISO:RGD.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; ISO:RGD.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IBA:GO_Central.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0009299; P:mRNA transcription; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISO:RGD.
DR   CDD; cd14229; STKc_HIPK3; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR050494; Ser_Thr_dual-spec_kinase.
DR   PANTHER; PTHR24058; DUAL SPECIFICITY PROTEIN KINASE; 1.
DR   PANTHER; PTHR24058:SF45; HOMEODOMAIN-INTERACTING PROTEIN KINASE 3; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   Apoptosis; ATP-binding; Isopeptide bond; Kinase; Nucleotide-binding;
KW   Nucleus; Phosphoprotein; Reference proteome;
KW   Serine/threonine-protein kinase; Transcription; Transcription regulation;
KW   Transferase; Ubl conjugation.
FT   CHAIN           1..1191
FT                   /note="Homeodomain-interacting protein kinase 3"
FT                   /id="PRO_0000086000"
FT   DOMAIN          197..525
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          766..920
FT                   /note="Interaction with AR"
FT                   /evidence="ECO:0000269|PubMed:9725910"
FT   REGION          774..867
FT                   /note="Interaction with FAS"
FT                   /evidence="ECO:0000250"
FT   REGION          801..828
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          846..856
FT                   /note="Interaction with UBL1"
FT                   /evidence="ECO:0000250"
FT   REGION          888..960
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          993..1022
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        801..823
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        888..911
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        923..956
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        322
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159,
FT                   ECO:0000255|PROSITE-ProRule:PRU10027"
FT   BINDING         203..211
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         226
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         359
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ERH7"
FT   CROSSLNK        27
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H422"
FT   MUTAGEN         226
FT                   /note="K->R: No enzymatic activity."
FT                   /evidence="ECO:0000269|PubMed:9725910"
FT   MUTAGEN         357
FT                   /note="S->A: Reduces enzymatic activity but no effect on
FT                   autophosphorylation; when associated with A-359."
FT                   /evidence="ECO:0000269|PubMed:9725910"
FT   MUTAGEN         359
FT                   /note="Y->A: Reduces enzymatic activity; but no effect on
FT                   autophosphorylation; when associated with A-357."
FT                   /evidence="ECO:0000269|PubMed:9725910"
SQ   SEQUENCE   1191 AA;  129744 MW;  0C2D05ED947A53ED CRC64;
     MASQVLVYPP YVYQTQSSAF CSVKKLKVEP SGCVFQERAC PQIHVNGRHF GNPLPSTKGS
     AFQTKIPFSK PRGHSFSLQA GAIVVKDTAG ATKVIAAQAQ QAGVEAPRAV VWRNRLHFLG
     GPQRCGLKRK SEELDNHSGA MQIVDELSIL PAMLQTNMGN PVTVVTATTG SKQNCTSGEG
     DYQLVQHEVL CSVKNTYEVL DFLGRGTFGQ VVKCWKRGTN EIVAIKILKN HPSYARQGQI
     EVSILARLST ENADEYNFVR AYECFQHRNH TCLVFEMLEQ NLYDFLKQNK FSPLPLKVIR
     PVLQQVATAL KKLKSLGLIH ADLKPENIML VDPVRQPYRV KVIDFGSASH VSKTVCSTYL
     QSRYYRAPEI ILGLPFCEAI DMWSLGCVIA ELFLGWPLYP GALEYDQIRY ISQTQGLPGE
     QLLNVGTKST RFFCRETDMS HSGWRLKTLE EHEAETGMKS KEARKYIFNS LDDIVHVNTV
     MDLEGSDLLA EKADRREFVS LLKKMLLIDA DLRITPIETL NHPFVSMKHL LDFPHSSHVK
     SCFHIMDICK SPSSCETNNH SKMSLLRPVA SNGTAALAAN FTKVGTLRSQ ALTTSAHSVV
     HHGIPLQAGT AQFGCGDAFH QTLIICPPAI QGIPAAHGKP TSYSIRVDNT VPLVTQAPAV
     QPLQIRPGVL SQTWSGRTQQ MLIPAWQQVT PMAPAAATLT SEGMAGSQRL GDWGKMIPHS
     NHYNSVMPPP LLTNQITLSA PQPISVGIAH VVWPQPATTK KNKLCQNRSN SLQNTNVPHS
     AFISPKIISG KEVEEVSCVE TQDNHTSEGE ARTCHEASVR QDSSVSDKQR QTIIIADSPS
     PAVSVITISS DTDDEETSPR PSLRECKGSL DCEACQSTLN IDRMCSLSSP DSTLSTSSSG
     QSSPSPCKRP NSMSDDEQES GCETVDGSPT SDSSGHDSPF AESSFVEDTP QNPELGTCAG
     TEAKPALSTA VEPPVGTERG LNVDAHMANT DSTCQPLTKG QPAPGKLNQP SASAARQQKP
     TSAFQQQHLN LSQVQHFGTG HQEWNGNFGH RRQQAYIPTS VTSNPFTLSH GSPNHTAVHA
     HLAGSAHLGG QPTLLPYPPS TALSSAAPVA HLLASPCTSR PMLQHPTYNI SHPSGIVHQV
     PVGINPRLLP SPTIHQTQYK PIFPPHSYIA ASPAYTGFPL SPTKLSQYPY M
//
